| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fish Proteins | 9 | 2025 | 13 | 4.190 |
Why?
|
| Fish Diseases | 9 | 2025 | 12 | 4.100 |
Why?
|
| Animals | 154 | 2025 | 13505 | 4.000 |
Why?
|
| Urethra | 7 | 2025 | 98 | 3.260 |
Why?
|
| Exosomes | 7 | 2025 | 58 | 3.090 |
Why?
|
| Oxidative Stress | 15 | 2025 | 807 | 2.950 |
Why?
|
| MicroRNAs | 13 | 2025 | 387 | 2.950 |
Why?
|
| Mice | 83 | 2025 | 5949 | 2.860 |
Why?
|
| Fishes | 4 | 2025 | 25 | 2.840 |
Why?
|
| Osteoblasts | 14 | 2025 | 475 | 2.510 |
Why?
|
| Hydrogels | 9 | 2025 | 23 | 2.390 |
Why?
|
| Speech Perception | 8 | 2025 | 98 | 2.260 |
Why?
|
| Humans | 161 | 2025 | 52483 | 2.030 |
Why?
|
| Solubility | 4 | 2024 | 79 | 1.990 |
Why?
|
| Perciformes | 2 | 2025 | 3 | 1.920 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2025 | 1563 | 1.910 |
Why?
|
| Neuronal Plasticity | 2 | 2025 | 45 | 1.830 |
Why?
|
| Depression, Postpartum | 2 | 2025 | 46 | 1.810 |
Why?
|
| Disease Models, Animal | 18 | 2025 | 1478 | 1.800 |
Why?
|
| Osteoclasts | 11 | 2024 | 428 | 1.740 |
Why?
|
| Cochlear Implants | 7 | 2023 | 67 | 1.720 |
Why?
|
| Erectile Dysfunction | 3 | 2025 | 93 | 1.720 |
Why?
|
| Wound Healing | 8 | 2025 | 219 | 1.700 |
Why?
|
| Male | 99 | 2025 | 26761 | 1.700 |
Why?
|
| Immunity, Innate | 12 | 2025 | 117 | 1.690 |
Why?
|
| Bone Resorption | 7 | 2024 | 302 | 1.590 |
Why?
|
| Ictaluridae | 3 | 2017 | 5 | 1.580 |
Why?
|
| Somatostatin | 4 | 2014 | 30 | 1.530 |
Why?
|
| RNA, Messenger | 19 | 2025 | 1132 | 1.510 |
Why?
|
| Water Pollutants, Chemical | 4 | 2025 | 54 | 1.490 |
Why?
|
| RANK Ligand | 13 | 2024 | 187 | 1.430 |
Why?
|
| Inflammation | 7 | 2025 | 641 | 1.390 |
Why?
|
| Carrier Proteins | 7 | 2015 | 313 | 1.390 |
Why?
|
| Tissue Engineering | 7 | 2025 | 74 | 1.380 |
Why?
|
| Nanoparticles | 7 | 2025 | 160 | 1.380 |
Why?
|
| Polymers | 4 | 2025 | 49 | 1.370 |
Why?
|
| Tissue Scaffolds | 5 | 2025 | 40 | 1.340 |
Why?
|
| Plant Extracts | 2 | 2024 | 194 | 1.320 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2025 | 326 | 1.320 |
Why?
|
| Gene Expression Profiling | 11 | 2025 | 1105 | 1.280 |
Why?
|
| Gene Expression Regulation | 20 | 2025 | 990 | 1.270 |
Why?
|
| Buffaloes | 8 | 2024 | 13 | 1.250 |
Why?
|
| Vitamin E | 6 | 2020 | 77 | 1.250 |
Why?
|
| Hearing Aids | 3 | 2023 | 70 | 1.230 |
Why?
|
| Signal Transduction | 23 | 2025 | 1671 | 1.220 |
Why?
|
| Female | 82 | 2025 | 28171 | 1.210 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2025 | 203 | 1.190 |
Why?
|
| Cell Proliferation | 11 | 2025 | 1023 | 1.190 |
Why?
|
| China | 22 | 2025 | 134 | 1.180 |
Why?
|
| Rats | 20 | 2025 | 3220 | 1.180 |
Why?
|
| Water | 4 | 2024 | 82 | 1.150 |
Why?
|
| Chromans | 5 | 2014 | 35 | 1.140 |
Why?
|
| Mice, Inbred C57BL | 24 | 2025 | 1884 | 1.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2025 | 169 | 1.130 |
Why?
|
| Radiation-Protective Agents | 7 | 2020 | 72 | 1.110 |
Why?
|
| Penis | 2 | 2025 | 84 | 1.110 |
Why?
|
| NF-kappa B | 7 | 2025 | 322 | 1.110 |
Why?
|
| Air Pollutants | 3 | 2023 | 75 | 1.090 |
Why?
|
| Transcriptome | 6 | 2025 | 370 | 1.070 |
Why?
|
| Antineoplastic Agents | 4 | 2025 | 1222 | 1.070 |
Why?
|
| Neoplasms | 9 | 2025 | 1325 | 1.070 |
Why?
|
| Heat-Shock Proteins | 3 | 2024 | 103 | 1.060 |
Why?
|
| Temperature | 3 | 2025 | 183 | 1.050 |
Why?
|
| Anti-Bacterial Agents | 7 | 2025 | 807 | 1.050 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2025 | 137 | 1.040 |
Why?
|
| Flavobacteriaceae Infections | 2 | 2016 | 2 | 1.040 |
Why?
|
| Enterobacteriaceae Infections | 2 | 2016 | 18 | 1.020 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 3 | 2025 | 20 | 1.020 |
Why?
|
| Cell-Derived Microparticles | 2 | 2017 | 20 | 1.020 |
Why?
|
| Acute Lung Injury | 2 | 2023 | 28 | 1.020 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2014 | 177 | 1.010 |
Why?
|
| Geologic Sediments | 2 | 2025 | 10 | 1.010 |
Why?
|
| Ovary | 2 | 2024 | 107 | 1.010 |
Why?
|
| Fluorescent Dyes | 2 | 2024 | 105 | 0.990 |
Why?
|
| Biological Availability | 4 | 2024 | 108 | 0.980 |
Why?
|
| Altitude Sickness | 1 | 2025 | 8 | 0.980 |
Why?
|
| Diclofenac | 1 | 2025 | 10 | 0.970 |
Why?
|
| Carbazoles | 1 | 2025 | 18 | 0.970 |
Why?
|
| Cathepsin D | 1 | 2025 | 4 | 0.960 |
Why?
|
| Cathepsin B | 1 | 2025 | 6 | 0.960 |
Why?
|
| Osteocytes | 4 | 2025 | 226 | 0.960 |
Why?
|
| Serum Albumin | 3 | 2014 | 58 | 0.960 |
Why?
|
| Music Therapy | 1 | 2025 | 3 | 0.960 |
Why?
|
| Proteomics | 10 | 2024 | 329 | 0.940 |
Why?
|
| Taste | 1 | 2025 | 30 | 0.940 |
Why?
|
| Crocus | 1 | 2024 | 1 | 0.940 |
Why?
|
| Brain Edema | 1 | 2025 | 36 | 0.940 |
Why?
|
| Chemokine CXCL12 | 1 | 2025 | 32 | 0.940 |
Why?
|
| Hypogonadism | 1 | 2024 | 11 | 0.940 |
Why?
|
| Urethral Stricture | 1 | 2025 | 23 | 0.930 |
Why?
|
| Atenolol | 1 | 2024 | 13 | 0.920 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2025 | 40 | 0.920 |
Why?
|
| Theca Cells | 1 | 2024 | 1 | 0.920 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2024 | 4 | 0.920 |
Why?
|
| Cicatrix | 1 | 2024 | 42 | 0.910 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2024 | 54 | 0.910 |
Why?
|
| Phylogeny | 10 | 2025 | 231 | 0.910 |
Why?
|
| Reactive Oxygen Species | 5 | 2025 | 421 | 0.910 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2018 | 111 | 0.910 |
Why?
|
| Mitochondrial Dynamics | 1 | 2024 | 23 | 0.900 |
Why?
|
| Azacitidine | 1 | 2024 | 39 | 0.900 |
Why?
|
| Pichia | 3 | 2014 | 8 | 0.900 |
Why?
|
| Cell Differentiation | 9 | 2024 | 665 | 0.900 |
Why?
|
| Gels | 1 | 2024 | 22 | 0.890 |
Why?
|
| Bariatric Surgery | 1 | 2025 | 43 | 0.890 |
Why?
|
| Graft Rejection | 2 | 2025 | 177 | 0.880 |
Why?
|
| Cochlear Implantation | 3 | 2023 | 81 | 0.880 |
Why?
|
| Aniline Compounds | 1 | 2024 | 46 | 0.880 |
Why?
|
| Cancer Vaccines | 1 | 2025 | 78 | 0.880 |
Why?
|
| Biosensing Techniques | 1 | 2024 | 30 | 0.880 |
Why?
|
| Sulfonamides | 2 | 2024 | 133 | 0.870 |
Why?
|
| Osteogenesis | 6 | 2025 | 366 | 0.870 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2024 | 57 | 0.860 |
Why?
|
| Ultrasonography, Interventional | 1 | 2025 | 140 | 0.860 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2025 | 595 | 0.860 |
Why?
|
| Regeneration | 3 | 2025 | 79 | 0.850 |
Why?
|
| Membrane Proteins | 2 | 2024 | 335 | 0.850 |
Why?
|
| Pyrazines | 1 | 2024 | 190 | 0.850 |
Why?
|
| Mice, Inbred BALB C | 11 | 2025 | 312 | 0.840 |
Why?
|
| Osteoarthritis | 1 | 2024 | 61 | 0.840 |
Why?
|
| Furans | 1 | 2023 | 30 | 0.830 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2023 | 4 | 0.830 |
Why?
|
| Ovule | 1 | 2023 | 1 | 0.820 |
Why?
|
| Kidney Transplantation | 2 | 2025 | 192 | 0.820 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2025 | 84 | 0.810 |
Why?
|
| Middle Aged | 36 | 2025 | 13028 | 0.810 |
Why?
|
| Apoptosis | 13 | 2025 | 1119 | 0.810 |
Why?
|
| Cisplatin | 2 | 2024 | 285 | 0.810 |
Why?
|
| Polyvinyl Alcohol | 1 | 2022 | 10 | 0.810 |
Why?
|
| Thalidomide | 1 | 2025 | 377 | 0.810 |
Why?
|
| Laparoscopy | 1 | 2025 | 180 | 0.800 |
Why?
|
| Chitosan | 4 | 2024 | 42 | 0.800 |
Why?
|
| Transplantation Tolerance | 2 | 2025 | 6 | 0.800 |
Why?
|
| Kidney Neoplasms | 4 | 2018 | 182 | 0.780 |
Why?
|
| Mitochondria | 7 | 2025 | 430 | 0.780 |
Why?
|
| Cell Line | 13 | 2024 | 1030 | 0.760 |
Why?
|
| Autophagy | 7 | 2025 | 193 | 0.760 |
Why?
|
| Proteome | 5 | 2020 | 171 | 0.760 |
Why?
|
| Adult | 34 | 2025 | 14161 | 0.750 |
Why?
|
| Graft Survival | 2 | 2025 | 160 | 0.750 |
Why?
|
| DNA | 2 | 2024 | 549 | 0.730 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2024 | 44 | 0.730 |
Why?
|
| Killer Cells, Natural | 5 | 2021 | 116 | 0.720 |
Why?
|
| Antiviral Agents | 2 | 2020 | 178 | 0.720 |
Why?
|
| Cell Line, Tumor | 10 | 2025 | 1470 | 0.720 |
Why?
|
| Bone Remodeling | 3 | 2025 | 155 | 0.710 |
Why?
|
| Postoperative Complications | 3 | 2025 | 1068 | 0.710 |
Why?
|
| Hemiptera | 4 | 2025 | 7 | 0.700 |
Why?
|
| Drugs, Chinese Herbal | 4 | 2025 | 9 | 0.700 |
Why?
|
| Stomach Neoplasms | 1 | 2024 | 194 | 0.700 |
Why?
|
| Cell Movement | 6 | 2024 | 268 | 0.700 |
Why?
|
| Proteoglycans | 3 | 2020 | 87 | 0.690 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 121 | 0.690 |
Why?
|
| Niclosamide | 1 | 2020 | 2 | 0.680 |
Why?
|
| Macrophages | 2 | 2025 | 379 | 0.680 |
Why?
|
| Melanoma | 1 | 2024 | 288 | 0.680 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 1031 | 0.680 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 145 | 0.670 |
Why?
|
| Immunosuppressive Agents | 2 | 2021 | 243 | 0.670 |
Why?
|
| Glass | 1 | 2019 | 4 | 0.660 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2019 | 8 | 0.650 |
Why?
|
| Coxsackievirus Infections | 1 | 2019 | 1 | 0.650 |
Why?
|
| Scutellaria baicalensis | 1 | 2019 | 1 | 0.650 |
Why?
|
| Behavior, Animal | 3 | 2025 | 185 | 0.650 |
Why?
|
| Neoplasm Proteins | 4 | 2020 | 334 | 0.640 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2025 | 560 | 0.620 |
Why?
|
| Streptococcus equi | 1 | 2019 | 2 | 0.620 |
Why?
|
| Carboxylesterase | 1 | 2019 | 4 | 0.620 |
Why?
|
| Spermatogenesis | 4 | 2024 | 13 | 0.620 |
Why?
|
| Zinc | 3 | 2024 | 56 | 0.620 |
Why?
|
| Schisandra | 1 | 2019 | 2 | 0.620 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2019 | 7 | 0.620 |
Why?
|
| Mutation | 5 | 2025 | 1347 | 0.620 |
Why?
|
| Bacterial Adhesion | 1 | 2019 | 16 | 0.620 |
Why?
|
| Flowers | 1 | 2018 | 11 | 0.620 |
Why?
|
| Drug Delivery Systems | 4 | 2025 | 154 | 0.620 |
Why?
|
| Gene Expression | 6 | 2017 | 618 | 0.620 |
Why?
|
| Fossils | 1 | 2018 | 20 | 0.620 |
Why?
|
| Escherichia coli | 6 | 2025 | 192 | 0.610 |
Why?
|
| Interleukin-23 | 1 | 2018 | 10 | 0.610 |
Why?
|
| Myocarditis | 1 | 2019 | 49 | 0.610 |
Why?
|
| Glutamine | 2 | 2022 | 176 | 0.600 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2025 | 151 | 0.600 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 372 | 0.600 |
Why?
|
| Drug Discovery | 3 | 2025 | 93 | 0.590 |
Why?
|
| Biological Evolution | 1 | 2018 | 52 | 0.580 |
Why?
|
| HeLa Cells | 6 | 2024 | 265 | 0.580 |
Why?
|
| Language | 2 | 2019 | 138 | 0.580 |
Why?
|
| Up-Regulation | 6 | 2023 | 454 | 0.570 |
Why?
|
| Whole-Body Irradiation | 7 | 2021 | 127 | 0.560 |
Why?
|
| Cholesterol | 1 | 2018 | 153 | 0.560 |
Why?
|
| Imipramine | 1 | 2017 | 13 | 0.550 |
Why?
|
| Endothelium, Vascular | 5 | 2018 | 246 | 0.550 |
Why?
|
| Chemokines, CC | 1 | 2017 | 9 | 0.550 |
Why?
|
| Coronary Artery Disease | 2 | 2023 | 294 | 0.550 |
Why?
|
| Models, Theoretical | 2 | 2019 | 185 | 0.550 |
Why?
|
| Phosphoproteins | 3 | 2024 | 119 | 0.550 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2017 | 29 | 0.540 |
Why?
|
| Peptides | 1 | 2018 | 223 | 0.540 |
Why?
|
| Preventive Health Services | 2 | 2019 | 52 | 0.540 |
Why?
|
| Treatment Outcome | 13 | 2025 | 5422 | 0.540 |
Why?
|
| Aging | 6 | 2025 | 701 | 0.540 |
Why?
|
| Chemokines, CXC | 1 | 2016 | 7 | 0.540 |
Why?
|
| Myocardium | 1 | 2019 | 453 | 0.540 |
Why?
|
| Cells, Cultured | 13 | 2020 | 1567 | 0.530 |
Why?
|
| Methylamines | 1 | 2016 | 20 | 0.520 |
Why?
|
| Intestinal Mucosa | 5 | 2021 | 224 | 0.520 |
Why?
|
| Radiation Injuries, Experimental | 3 | 2019 | 81 | 0.520 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 75 | 0.520 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2025 | 42 | 0.520 |
Why?
|
| Health Communication | 1 | 2016 | 23 | 0.510 |
Why?
|
| Stress, Physiological | 2 | 2024 | 183 | 0.510 |
Why?
|
| Prefrontal Cortex | 3 | 2025 | 85 | 0.500 |
Why?
|
| Parathyroid Hormone | 7 | 2017 | 149 | 0.500 |
Why?
|
| Immune Tolerance | 4 | 2021 | 91 | 0.490 |
Why?
|
| Septins | 1 | 2015 | 20 | 0.490 |
Why?
|
| Abortion, Spontaneous | 3 | 2022 | 21 | 0.490 |
Why?
|
| Intestines | 6 | 2021 | 154 | 0.490 |
Why?
|
| Immunotherapy | 4 | 2025 | 244 | 0.490 |
Why?
|
| Calcium | 4 | 2025 | 376 | 0.490 |
Why?
|
| NF-E2-Related Factor 2 | 4 | 2024 | 47 | 0.490 |
Why?
|
| Lipopolysaccharides | 4 | 2025 | 206 | 0.490 |
Why?
|
| Subcellular Fractions | 1 | 2015 | 34 | 0.490 |
Why?
|
| Tomography, Optical Coherence | 1 | 2016 | 109 | 0.490 |
Why?
|
| Blood Glucose | 3 | 2022 | 473 | 0.480 |
Why?
|
| Agglutination | 2 | 2025 | 3 | 0.480 |
Why?
|
| Administration, Oral | 4 | 2025 | 451 | 0.480 |
Why?
|
| Aeromonas salmonicida | 2 | 2025 | 4 | 0.480 |
Why?
|
| Membrane Glycoproteins | 4 | 2006 | 244 | 0.480 |
Why?
|
| Hyperglycemia | 1 | 2015 | 88 | 0.480 |
Why?
|
| Aged | 20 | 2025 | 10121 | 0.480 |
Why?
|
| Time Factors | 8 | 2025 | 2968 | 0.470 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2025 | 26 | 0.470 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2025 | 35 | 0.460 |
Why?
|
| Hyaluronic Acid | 2 | 2025 | 38 | 0.460 |
Why?
|
| Cell Communication | 1 | 2015 | 71 | 0.460 |
Why?
|
| Copper | 2 | 2025 | 47 | 0.460 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 804 | 0.460 |
Why?
|
| Mevalonic Acid | 1 | 2014 | 5 | 0.460 |
Why?
|
| Hippocampus | 3 | 2025 | 201 | 0.460 |
Why?
|
| Ribes | 2 | 2025 | 5 | 0.450 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 189 | 0.450 |
Why?
|
| Somatostatin-28 | 1 | 2014 | 3 | 0.450 |
Why?
|
| Bone Regeneration | 2 | 2025 | 70 | 0.450 |
Why?
|
| Receptors, Somatostatin | 1 | 2014 | 3 | 0.450 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 50 | 0.450 |
Why?
|
| Emulsions | 1 | 2014 | 25 | 0.450 |
Why?
|
| Fibrosis | 4 | 2024 | 196 | 0.440 |
Why?
|
| Testosterone | 2 | 2024 | 141 | 0.440 |
Why?
|
| Metals, Heavy | 3 | 2020 | 11 | 0.440 |
Why?
|
| Microglia | 2 | 2025 | 113 | 0.440 |
Why?
|
| Fibroblasts | 5 | 2020 | 355 | 0.440 |
Why?
|
| Streptococcal Infections | 4 | 2019 | 49 | 0.440 |
Why?
|
| Hydrogen Peroxide | 3 | 2024 | 120 | 0.430 |
Why?
|
| Insecticides | 2 | 2024 | 17 | 0.430 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 1212 | 0.430 |
Why?
|
| Phosphorylation | 9 | 2024 | 528 | 0.420 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2011 | 58 | 0.420 |
Why?
|
| Protein Engineering | 1 | 2013 | 20 | 0.420 |
Why?
|
| Antigens, CD | 2 | 2025 | 218 | 0.420 |
Why?
|
| Mass Screening | 1 | 2016 | 357 | 0.420 |
Why?
|
| Flatfishes | 3 | 2017 | 3 | 0.410 |
Why?
|
| Adenosine | 3 | 2025 | 71 | 0.410 |
Why?
|
| Environmental Monitoring | 5 | 2020 | 74 | 0.410 |
Why?
|
| Immune Evasion | 3 | 2018 | 15 | 0.400 |
Why?
|
| Molecular Chaperones | 2 | 2024 | 66 | 0.400 |
Why?
|
| Drug Stability | 2 | 2024 | 38 | 0.400 |
Why?
|
| Pancreas | 2 | 2011 | 71 | 0.400 |
Why?
|
| Young Adult | 14 | 2025 | 4329 | 0.400 |
Why?
|
| Tumor Microenvironment | 6 | 2025 | 256 | 0.400 |
Why?
|
| Drug Compounding | 2 | 2024 | 28 | 0.390 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 422 | 0.390 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2020 | 202 | 0.390 |
Why?
|
| Smoking Cessation | 3 | 2023 | 315 | 0.390 |
Why?
|
| Prognosis | 13 | 2025 | 2099 | 0.390 |
Why?
|
| Autoimmune Diseases | 2 | 2025 | 86 | 0.380 |
Why?
|
| Collagen | 4 | 2021 | 211 | 0.380 |
Why?
|
| Obesity | 4 | 2025 | 1162 | 0.370 |
Why?
|
| Osteoprotegerin | 3 | 2023 | 53 | 0.370 |
Why?
|
| Retrospective Studies | 12 | 2025 | 6607 | 0.370 |
Why?
|
| Carcinoma, Transitional Cell | 3 | 2021 | 54 | 0.370 |
Why?
|
| Brain Neoplasms | 2 | 2025 | 291 | 0.360 |
Why?
|
| Rabbits | 5 | 2024 | 375 | 0.360 |
Why?
|
| Liver Neoplasms | 3 | 2020 | 333 | 0.360 |
Why?
|
| Radiation, Ionizing | 4 | 2022 | 101 | 0.360 |
Why?
|
| Lymphocytes | 2 | 2025 | 153 | 0.350 |
Why?
|
| Acoustic Stimulation | 4 | 2025 | 93 | 0.350 |
Why?
|
| Auditory Threshold | 4 | 2025 | 54 | 0.350 |
Why?
|
| Particulate Matter | 2 | 2023 | 63 | 0.350 |
Why?
|
| Staphylococcus aureus | 5 | 2025 | 338 | 0.350 |
Why?
|
| Mice, Knockout | 8 | 2025 | 879 | 0.350 |
Why?
|
| Mice, Nude | 4 | 2025 | 265 | 0.340 |
Why?
|
| Molecular Structure | 4 | 2025 | 314 | 0.340 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2025 | 164 | 0.340 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2021 | 165 | 0.340 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 332 | 0.340 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2020 | 49 | 0.330 |
Why?
|
| Environmental Exposure | 2 | 2023 | 216 | 0.330 |
Why?
|
| Metamorphosis, Biological | 1 | 2009 | 2 | 0.330 |
Why?
|
| Moths | 1 | 2009 | 5 | 0.330 |
Why?
|
| Abortion, Habitual | 2 | 2021 | 4 | 0.330 |
Why?
|
| Genetic Variation | 2 | 2025 | 230 | 0.330 |
Why?
|
| Epidermis | 1 | 2009 | 32 | 0.330 |
Why?
|
| Myocytes, Cardiac | 3 | 2021 | 129 | 0.320 |
Why?
|
| Polyethylene Glycols | 3 | 2021 | 90 | 0.320 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2025 | 339 | 0.320 |
Why?
|
| Prostatic Neoplasms | 3 | 2025 | 398 | 0.320 |
Why?
|
| Prospective Studies | 5 | 2025 | 2481 | 0.320 |
Why?
|
| Transcription Factors | 3 | 2024 | 566 | 0.310 |
Why?
|
| Risk Assessment | 5 | 2021 | 1327 | 0.310 |
Why?
|
| Stress, Psychological | 2 | 2025 | 273 | 0.310 |
Why?
|
| Thrombomodulin | 2 | 2008 | 26 | 0.310 |
Why?
|
| Adolescent | 11 | 2025 | 6739 | 0.310 |
Why?
|
| Vibrio Infections | 3 | 2017 | 3 | 0.310 |
Why?
|
| Kinetics | 4 | 2024 | 626 | 0.310 |
Why?
|
| Lim Kinases | 1 | 2008 | 1 | 0.310 |
Why?
|
| Risk Factors | 8 | 2025 | 3889 | 0.300 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2020 | 134 | 0.300 |
Why?
|
| Cytoskeleton | 1 | 2008 | 39 | 0.300 |
Why?
|
| Amino Acid Sequence | 4 | 2025 | 578 | 0.290 |
Why?
|
| Antibodies | 2 | 2019 | 159 | 0.290 |
Why?
|
| Alleles | 3 | 2025 | 276 | 0.290 |
Why?
|
| Actins | 1 | 2008 | 115 | 0.290 |
Why?
|
| Pregnancy | 12 | 2023 | 2680 | 0.290 |
Why?
|
| Interferon-alpha | 2 | 2020 | 53 | 0.290 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2021 | 307 | 0.290 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 133 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2022 | 399 | 0.290 |
Why?
|
| Quality of Life | 3 | 2023 | 879 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2025 | 202 | 0.280 |
Why?
|
| Antibodies, Monoclonal | 2 | 2025 | 481 | 0.280 |
Why?
|
| Glycolysis | 2 | 2020 | 73 | 0.280 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2024 | 19 | 0.280 |
Why?
|
| Extracellular Matrix | 3 | 2017 | 112 | 0.280 |
Why?
|
| Radiation Dosage | 4 | 2023 | 163 | 0.280 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2006 | 34 | 0.280 |
Why?
|
| Oocytes | 2 | 2018 | 92 | 0.280 |
Why?
|
| Kidney | 2 | 2023 | 707 | 0.270 |
Why?
|
| Lactic Acid | 3 | 2023 | 78 | 0.270 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2025 | 227 | 0.270 |
Why?
|
| Protein Binding | 6 | 2021 | 667 | 0.270 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 220 | 0.270 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 3 | 2025 | 99 | 0.270 |
Why?
|
| Testis | 3 | 2024 | 72 | 0.270 |
Why?
|
| Case-Control Studies | 6 | 2025 | 1201 | 0.260 |
Why?
|
| Placenta | 2 | 2020 | 153 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2025 | 166 | 0.260 |
Why?
|
| Teriparatide | 1 | 2006 | 10 | 0.260 |
Why?
|
| Edwardsiella ictaluri | 2 | 2016 | 2 | 0.260 |
Why?
|
| Flavobacterium | 2 | 2016 | 3 | 0.260 |
Why?
|
| Polyesters | 3 | 2021 | 14 | 0.260 |
Why?
|
| Galectins | 2 | 2017 | 7 | 0.260 |
Why?
|
| Limit of Detection | 2 | 2024 | 21 | 0.260 |
Why?
|
| Jejunum | 2 | 2021 | 55 | 0.260 |
Why?
|
| Urinary Bladder | 4 | 2025 | 101 | 0.260 |
Why?
|
| Molecular Sequence Data | 5 | 2016 | 778 | 0.250 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 649 | 0.250 |
Why?
|
| Brain Injuries | 2 | 2022 | 159 | 0.250 |
Why?
|
| Hepatopancreas | 1 | 2025 | 1 | 0.250 |
Why?
|
| White spot syndrome virus 1 | 1 | 2025 | 1 | 0.250 |
Why?
|
| Penaeidae | 1 | 2025 | 4 | 0.250 |
Why?
|
| Survival Rate | 5 | 2025 | 945 | 0.250 |
Why?
|
| Integrin beta Chains | 1 | 2025 | 14 | 0.250 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2025 | 7 | 0.250 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2025 | 19 | 0.240 |
Why?
|
| Solid Waste | 1 | 2025 | 2 | 0.240 |
Why?
|
| Recycling | 1 | 2025 | 3 | 0.240 |
Why?
|
| Cattle Diseases | 1 | 2025 | 14 | 0.240 |
Why?
|
| PQQ Cofactor | 1 | 2025 | 1 | 0.240 |
Why?
|
| Exploratory Behavior | 1 | 2025 | 24 | 0.240 |
Why?
|
| Alcohols | 1 | 2025 | 9 | 0.240 |
Why?
|
| Silicone Elastomers | 1 | 2025 | 9 | 0.240 |
Why?
|
| Dentate Gyrus | 1 | 2025 | 19 | 0.240 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2021 | 44 | 0.240 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2025 | 1 | 0.240 |
Why?
|
| Poly I-C | 1 | 2025 | 6 | 0.240 |
Why?
|
| HLA-B Antigens | 1 | 2025 | 8 | 0.240 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2025 | 5 | 0.240 |
Why?
|
| HLA-C Antigens | 1 | 2025 | 5 | 0.240 |
Why?
|
| Silk | 1 | 2025 | 1 | 0.240 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2025 | 19 | 0.240 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2025 | 3 | 0.240 |
Why?
|
| Pinealoma | 1 | 2025 | 7 | 0.240 |
Why?
|
| Viruses | 1 | 2025 | 25 | 0.240 |
Why?
|
| Muramidase | 1 | 2025 | 15 | 0.240 |
Why?
|
| Central Nervous System Infections | 1 | 2025 | 7 | 0.240 |
Why?
|
| Pineal Gland | 1 | 2025 | 9 | 0.240 |
Why?
|
| Expressed Sequence Tags | 1 | 2025 | 8 | 0.240 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2025 | 55 | 0.240 |
Why?
|
| Intestine, Small | 2 | 2021 | 115 | 0.240 |
Why?
|
| Perceptual Masking | 1 | 2025 | 11 | 0.240 |
Why?
|
| Seasons | 3 | 2024 | 92 | 0.240 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2025 | 35 | 0.240 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 9 | 0.240 |
Why?
|
| Microsatellite Repeats | 1 | 2025 | 42 | 0.240 |
Why?
|
| Semaphorins | 1 | 2025 | 5 | 0.240 |
Why?
|
| Lumbar Vertebrae | 2 | 2025 | 104 | 0.240 |
Why?
|
| Saliva | 1 | 2025 | 56 | 0.240 |
Why?
|
| Core Binding Factors | 1 | 2025 | 3 | 0.240 |
Why?
|
| Neurogenesis | 1 | 2025 | 27 | 0.240 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2025 | 10 | 0.240 |
Why?
|
| Lung | 3 | 2025 | 509 | 0.240 |
Why?
|
| Cystitis | 1 | 2025 | 17 | 0.240 |
Why?
|
| Epigenomics | 1 | 2025 | 75 | 0.240 |
Why?
|
| Cynodon | 1 | 2024 | 1 | 0.240 |
Why?
|
| DNA Shuffling | 1 | 2024 | 1 | 0.240 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2025 | 178 | 0.240 |
Why?
|
| Leydig Cells | 1 | 2024 | 9 | 0.240 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2024 | 1 | 0.230 |
Why?
|
| Artemisia annua | 1 | 2024 | 1 | 0.230 |
Why?
|
| Genotype | 2 | 2024 | 566 | 0.230 |
Why?
|
| Methyltransferases | 1 | 2025 | 29 | 0.230 |
Why?
|
| Galactose | 1 | 2024 | 29 | 0.230 |
Why?
|
| Membrane Transport Proteins | 2 | 2015 | 46 | 0.230 |
Why?
|
| Bone and Bones | 3 | 2025 | 494 | 0.230 |
Why?
|
| Anabolic Agents | 1 | 2025 | 44 | 0.230 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2024 | 11 | 0.230 |
Why?
|
| Diarrhea | 1 | 2025 | 95 | 0.230 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2024 | 14 | 0.230 |
Why?
|
| Heart Failure | 2 | 2023 | 565 | 0.230 |
Why?
|
| Uveitis | 1 | 2025 | 23 | 0.230 |
Why?
|
| African Swine Fever | 1 | 2024 | 1 | 0.230 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2024 | 8 | 0.230 |
Why?
|
| African Swine Fever Virus | 1 | 2024 | 2 | 0.230 |
Why?
|
| Catechin | 1 | 2024 | 16 | 0.230 |
Why?
|
| Virus Diseases | 1 | 2025 | 46 | 0.230 |
Why?
|
| Anastomosis, Surgical | 1 | 2025 | 68 | 0.230 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2024 | 8 | 0.230 |
Why?
|
| Pulmonary Alveoli | 1 | 2025 | 25 | 0.230 |
Why?
|
| Neuroimaging | 1 | 2025 | 94 | 0.230 |
Why?
|
| Reference Values | 2 | 2023 | 313 | 0.230 |
Why?
|
| Soft Tissue Infections | 1 | 2024 | 18 | 0.230 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2024 | 13 | 0.230 |
Why?
|
| Quorum Sensing | 1 | 2024 | 10 | 0.230 |
Why?
|
| Biotechnology | 1 | 2024 | 15 | 0.230 |
Why?
|
| Crassostrea | 1 | 2024 | 2 | 0.230 |
Why?
|
| Maleimides | 1 | 2024 | 8 | 0.230 |
Why?
|
| Biphenyl Compounds | 1 | 2024 | 31 | 0.230 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2025 | 90 | 0.230 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2024 | 19 | 0.230 |
Why?
|
| Epigenesis, Genetic | 2 | 2025 | 406 | 0.230 |
Why?
|
| Aged, 80 and over | 7 | 2025 | 3392 | 0.230 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2024 | 39 | 0.230 |
Why?
|
| tau Proteins | 1 | 2024 | 27 | 0.230 |
Why?
|
| Vancomycin | 1 | 2025 | 85 | 0.230 |
Why?
|
| Urinary Tract Infections | 1 | 2025 | 57 | 0.230 |
Why?
|
| Peroxidase | 1 | 2024 | 17 | 0.230 |
Why?
|
| Charcoal | 1 | 2024 | 6 | 0.230 |
Why?
|
| Pseudomonas Infections | 1 | 2024 | 54 | 0.230 |
Why?
|
| Speech Reception Threshold Test | 2 | 2025 | 4 | 0.230 |
Why?
|
| Stromal Cells | 3 | 2020 | 79 | 0.220 |
Why?
|
| Tinnitus | 1 | 2025 | 60 | 0.220 |
Why?
|
| Radiation Injuries | 4 | 2010 | 110 | 0.220 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2024 | 78 | 0.220 |
Why?
|
| Thiophenes | 1 | 2024 | 38 | 0.220 |
Why?
|
| Reproduction | 2 | 2024 | 64 | 0.220 |
Why?
|
| Kidney Tubules | 1 | 2024 | 62 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2020 | 1378 | 0.220 |
Why?
|
| Biocompatible Materials | 1 | 2024 | 67 | 0.220 |
Why?
|
| Nanofibers | 2 | 2021 | 8 | 0.220 |
Why?
|
| Cell Death | 1 | 2025 | 177 | 0.220 |
Why?
|
| Longevity | 1 | 2024 | 85 | 0.220 |
Why?
|
| Skin | 2 | 2023 | 422 | 0.220 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 66 | 0.220 |
Why?
|
| Immunologic Factors | 1 | 2025 | 117 | 0.220 |
Why?
|
| Umbilical Cord | 1 | 2024 | 36 | 0.220 |
Why?
|
| Lung Diseases | 1 | 2025 | 88 | 0.220 |
Why?
|
| Periosteum | 1 | 2024 | 26 | 0.220 |
Why?
|
| Mammals | 1 | 2024 | 61 | 0.220 |
Why?
|
| 3' Untranslated Regions | 1 | 2024 | 55 | 0.220 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2024 | 185 | 0.220 |
Why?
|
| Grossulariaceae | 1 | 2023 | 1 | 0.220 |
Why?
|
| Osteolysis | 1 | 2024 | 75 | 0.220 |
Why?
|
| Genome, Chloroplast | 1 | 2023 | 2 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 229 | 0.220 |
Why?
|
| Mass Spectrometry | 1 | 2025 | 292 | 0.220 |
Why?
|
| Neurosurgical Procedures | 1 | 2025 | 135 | 0.220 |
Why?
|
| Nuclear Proteins | 1 | 2025 | 245 | 0.220 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 15 | 0.220 |
Why?
|
| Spermatozoa | 2 | 2020 | 25 | 0.220 |
Why?
|
| Cyclophosphamide | 1 | 2024 | 171 | 0.220 |
Why?
|
| Photochemotherapy | 1 | 2024 | 34 | 0.220 |
Why?
|
| Optical Devices | 1 | 2023 | 3 | 0.220 |
Why?
|
| Lymphatic Vessels | 1 | 2024 | 55 | 0.210 |
Why?
|
| Deafness | 3 | 2019 | 35 | 0.210 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2025 | 53 | 0.210 |
Why?
|
| Stilbenes | 1 | 2024 | 58 | 0.210 |
Why?
|
| Radiation Tolerance | 1 | 2024 | 84 | 0.210 |
Why?
|
| Pharmaceutical Preparations | 1 | 2024 | 77 | 0.210 |
Why?
|
| Hydrocarbons | 1 | 2023 | 14 | 0.210 |
Why?
|
| Databases, Genetic | 2 | 2021 | 83 | 0.210 |
Why?
|
| Glioblastoma | 1 | 2025 | 97 | 0.210 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 94 | 0.210 |
Why?
|
| Glomerular Filtration Rate | 1 | 2023 | 124 | 0.210 |
Why?
|
| Brain Ischemia | 2 | 2022 | 161 | 0.210 |
Why?
|
| Antihypertensive Agents | 1 | 2024 | 132 | 0.210 |
Why?
|
| Microscopy | 1 | 2023 | 60 | 0.210 |
Why?
|
| Liver | 3 | 2017 | 1156 | 0.210 |
Why?
|
| Chemokine CXCL9 | 2 | 2016 | 9 | 0.210 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2003 | 50 | 0.210 |
Why?
|
| Macrophages, Alveolar | 1 | 2023 | 30 | 0.210 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2021 | 181 | 0.210 |
Why?
|
| Plasma Cells | 1 | 2025 | 239 | 0.210 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2023 | 6 | 0.210 |
Why?
|
| Acupuncture Therapy | 1 | 2023 | 5 | 0.210 |
Why?
|
| Allosteric Regulation | 2 | 2019 | 16 | 0.210 |
Why?
|
| Dependovirus | 1 | 2024 | 103 | 0.210 |
Why?
|
| Alkaloids | 2 | 2020 | 35 | 0.210 |
Why?
|
| Islets of Langerhans | 1 | 2023 | 26 | 0.210 |
Why?
|
| Soil Pollutants | 2 | 2020 | 12 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 857 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2023 | 182 | 0.210 |
Why?
|
| Glycoproteins | 2 | 2005 | 122 | 0.210 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2023 | 24 | 0.210 |
Why?
|
| Spine | 2 | 2022 | 89 | 0.200 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 128 | 0.200 |
Why?
|
| Genitalia, Female | 1 | 2023 | 19 | 0.200 |
Why?
|
| Pitch Perception | 2 | 2019 | 10 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 115 | 0.200 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 59 | 0.200 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 944 | 0.200 |
Why?
|
| X-Ray Microtomography | 1 | 2023 | 79 | 0.200 |
Why?
|
| Parkinson Disease | 1 | 2025 | 155 | 0.200 |
Why?
|
| Fluorescence | 1 | 2022 | 39 | 0.200 |
Why?
|
| Carbon Dioxide | 1 | 2023 | 97 | 0.200 |
Why?
|
| Solvents | 1 | 2022 | 33 | 0.200 |
Why?
|
| Osteomyelitis | 1 | 2024 | 125 | 0.200 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2022 | 42 | 0.200 |
Why?
|
| Coloring Agents | 1 | 2022 | 69 | 0.200 |
Why?
|
| Coptis | 1 | 2022 | 1 | 0.200 |
Why?
|
| Brain | 3 | 2025 | 1323 | 0.200 |
Why?
|
| Panax | 1 | 2022 | 8 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 67 | 0.190 |
Why?
|
| Disease Resistance | 2 | 2025 | 9 | 0.190 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2022 | 40 | 0.190 |
Why?
|
| Dexamethasone | 1 | 2024 | 438 | 0.190 |
Why?
|
| Lysine | 2 | 2020 | 89 | 0.190 |
Why?
|
| Counseling | 2 | 2023 | 136 | 0.190 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2022 | 4 | 0.190 |
Why?
|
| Clinical Trials as Topic | 1 | 2025 | 467 | 0.190 |
Why?
|
| Parthenogenesis | 2 | 2020 | 3 | 0.190 |
Why?
|
| Poverty | 3 | 2023 | 219 | 0.190 |
Why?
|
| Leukocyte Elastase | 1 | 2022 | 6 | 0.190 |
Why?
|
| Stem Cells | 3 | 2021 | 177 | 0.190 |
Why?
|
| Fibrosarcoma | 1 | 2022 | 16 | 0.190 |
Why?
|
| Transfection | 3 | 2024 | 357 | 0.190 |
Why?
|
| Virulence | 4 | 2025 | 167 | 0.190 |
Why?
|
| Cytokines | 4 | 2025 | 623 | 0.190 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 35 | 0.190 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2022 | 12 | 0.190 |
Why?
|
| Ki-67 Antigen | 2 | 2019 | 58 | 0.190 |
Why?
|
| Stichopus | 1 | 2021 | 1 | 0.190 |
Why?
|
| Energy Metabolism | 1 | 2024 | 302 | 0.190 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2019 | 253 | 0.190 |
Why?
|
| Peptides, Cyclic | 1 | 2022 | 42 | 0.190 |
Why?
|
| Indoles | 1 | 2024 | 278 | 0.190 |
Why?
|
| Receptors, CXCR4 | 1 | 2021 | 29 | 0.190 |
Why?
|
| Colonic Neoplasms | 2 | 2020 | 163 | 0.190 |
Why?
|
| STAT1 Transcription Factor | 2 | 2025 | 27 | 0.190 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 299 | 0.180 |
Why?
|
| Molecular Docking Simulation | 2 | 2019 | 88 | 0.180 |
Why?
|
| Health Facilities | 1 | 2021 | 40 | 0.180 |
Why?
|
| Cocaine | 1 | 2023 | 177 | 0.180 |
Why?
|
| Duodenum | 1 | 2021 | 34 | 0.180 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 106 | 0.180 |
Why?
|
| Sertoli Cells | 1 | 2021 | 4 | 0.180 |
Why?
|
| Sequence Deletion | 2 | 2019 | 73 | 0.180 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2025 | 483 | 0.180 |
Why?
|
| Molecular Conformation | 2 | 2018 | 70 | 0.180 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2021 | 2 | 0.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2023 | 197 | 0.180 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 285 | 0.180 |
Why?
|
| Lymphocyte Activation | 2 | 2018 | 172 | 0.180 |
Why?
|
| Health Behavior | 2 | 2023 | 257 | 0.180 |
Why?
|
| Pilot Projects | 3 | 2023 | 721 | 0.180 |
Why?
|
| Ileum | 1 | 2021 | 88 | 0.180 |
Why?
|
| RNA Editing | 1 | 2020 | 2 | 0.180 |
Why?
|
| Ubiquitinated Proteins | 1 | 2020 | 2 | 0.180 |
Why?
|
| Heart Injuries | 1 | 2021 | 16 | 0.180 |
Why?
|
| Extraction, Obstetrical | 1 | 2020 | 4 | 0.180 |
Why?
|
| Episiotomy | 1 | 2020 | 7 | 0.180 |
Why?
|
| Epididymis | 1 | 2020 | 8 | 0.180 |
Why?
|
| Logistic Models | 3 | 2023 | 925 | 0.180 |
Why?
|
| Safety Management | 1 | 2021 | 36 | 0.180 |
Why?
|
| Parity | 1 | 2020 | 52 | 0.170 |
Why?
|
| Child | 7 | 2025 | 7248 | 0.170 |
Why?
|
| Anaerobiosis | 2 | 2019 | 20 | 0.170 |
Why?
|
| Blotting, Western | 4 | 2016 | 590 | 0.170 |
Why?
|
| Probucol | 1 | 2020 | 4 | 0.170 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2020 | 7 | 0.170 |
Why?
|
| Glucose | 2 | 2020 | 355 | 0.170 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2020 | 1 | 0.170 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2020 | 2 | 0.170 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2020 | 2 | 0.170 |
Why?
|
| Poloxamer | 1 | 2020 | 1 | 0.170 |
Why?
|
| Noise | 2 | 2025 | 41 | 0.170 |
Why?
|
| Phenotype | 3 | 2024 | 789 | 0.170 |
Why?
|
| Cyclic AMP | 2 | 2014 | 91 | 0.170 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2020 | 3 | 0.170 |
Why?
|
| Obesity, Abdominal | 1 | 2020 | 18 | 0.170 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2020 | 9 | 0.170 |
Why?
|
| T-Box Domain Proteins | 1 | 2020 | 14 | 0.170 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 15 | 0.170 |
Why?
|
| Hedgehog Proteins | 1 | 2020 | 34 | 0.170 |
Why?
|
| Carnitine | 2 | 2017 | 68 | 0.170 |
Why?
|
| Magnetite Nanoparticles | 1 | 2020 | 23 | 0.170 |
Why?
|
| Proteins | 2 | 2020 | 348 | 0.170 |
Why?
|
| Blood Donors | 1 | 2020 | 21 | 0.170 |
Why?
|
| Disease Progression | 3 | 2020 | 871 | 0.170 |
Why?
|
| Sirolimus | 1 | 2020 | 65 | 0.170 |
Why?
|
| Patient Safety | 1 | 2021 | 104 | 0.170 |
Why?
|
| Postpartum Hemorrhage | 1 | 2020 | 39 | 0.170 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2020 | 45 | 0.170 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2020 | 64 | 0.170 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2021 | 405 | 0.170 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 146 | 0.170 |
Why?
|
| Dementia | 1 | 2021 | 134 | 0.160 |
Why?
|
| Bronchiolitis | 1 | 2020 | 28 | 0.160 |
Why?
|
| Lycium | 1 | 2019 | 1 | 0.160 |
Why?
|
| Oncogene Proteins | 1 | 2019 | 19 | 0.160 |
Why?
|
| Semen Analysis | 1 | 2019 | 3 | 0.160 |
Why?
|
| Diabetic Neuropathies | 1 | 2020 | 56 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2024 | 251 | 0.160 |
Why?
|
| Patient Selection | 1 | 2021 | 259 | 0.160 |
Why?
|
| Enterovirus | 1 | 2019 | 8 | 0.160 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 186 | 0.160 |
Why?
|
| Quantum Theory | 1 | 2019 | 2 | 0.160 |
Why?
|
| Psychometrics | 1 | 2021 | 230 | 0.160 |
Why?
|
| Respiratory Sounds | 1 | 2020 | 50 | 0.160 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2019 | 13 | 0.160 |
Why?
|
| Ribavirin | 1 | 2019 | 15 | 0.160 |
Why?
|
| Umbelliferones | 1 | 2019 | 1 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 109 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 69 | 0.160 |
Why?
|
| Animal Feed | 1 | 2019 | 56 | 0.160 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 187 | 0.160 |
Why?
|
| Cattle | 3 | 2025 | 205 | 0.160 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2019 | 23 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 85 | 0.160 |
Why?
|
| Psychoacoustics | 1 | 2019 | 5 | 0.160 |
Why?
|
| Pitch Discrimination | 1 | 2019 | 5 | 0.160 |
Why?
|
| Pregnancy, Unwanted | 1 | 2019 | 4 | 0.160 |
Why?
|
| Pregnancy, Unplanned | 1 | 2019 | 5 | 0.160 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 72 | 0.160 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2019 | 20 | 0.160 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2020 | 58 | 0.160 |
Why?
|
| Contraception Behavior | 1 | 2019 | 12 | 0.160 |
Why?
|
| Speech Acoustics | 1 | 2019 | 19 | 0.160 |
Why?
|
| Manure | 1 | 2019 | 1 | 0.160 |
Why?
|
| Doxorubicin | 1 | 2021 | 241 | 0.160 |
Why?
|
| Dioxoles | 1 | 2019 | 2 | 0.160 |
Why?
|
| Cesarean Section | 1 | 2020 | 184 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2025 | 132 | 0.160 |
Why?
|
| Cyclooctanes | 1 | 2019 | 3 | 0.160 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 340 | 0.160 |
Why?
|
| Methane | 1 | 2019 | 11 | 0.160 |
Why?
|
| Polycyclic Compounds | 1 | 2019 | 8 | 0.160 |
Why?
|
| Enzymes | 1 | 2019 | 29 | 0.160 |
Why?
|
| Lignans | 1 | 2019 | 7 | 0.160 |
Why?
|
| Patient Navigation | 1 | 2019 | 13 | 0.160 |
Why?
|
| Superoxide Dismutase | 3 | 2025 | 119 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 1 | 2019 | 57 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2019 | 74 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 137 | 0.150 |
Why?
|
| Helicobacter pylori | 1 | 2019 | 65 | 0.150 |
Why?
|
| Hyperparathyroidism | 2 | 2011 | 31 | 0.150 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2019 | 35 | 0.150 |
Why?
|
| Bacterial Capsules | 1 | 2019 | 19 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2018 | 17 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-hck | 1 | 2018 | 1 | 0.150 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 166 | 0.150 |
Why?
|
| Berberine Alkaloids | 1 | 2018 | 1 | 0.150 |
Why?
|
| Human Activities | 1 | 2018 | 7 | 0.150 |
Why?
|
| Heptanoic Acids | 2 | 2008 | 34 | 0.150 |
Why?
|
| Isodon | 1 | 2018 | 1 | 0.150 |
Why?
|
| Proportional Hazards Models | 4 | 2025 | 443 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2020 | 82 | 0.150 |
Why?
|
| Micelles | 1 | 2018 | 8 | 0.150 |
Why?
|
| Endometrium | 1 | 2018 | 43 | 0.150 |
Why?
|
| Receptors, IgG | 1 | 2018 | 24 | 0.150 |
Why?
|
| Diterpenes, Clerodane | 1 | 2018 | 21 | 0.150 |
Why?
|
| Cyclooxygenase 2 | 1 | 2018 | 48 | 0.150 |
Why?
|
| Drug Interactions | 1 | 2019 | 206 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 59 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 582 | 0.150 |
Why?
|
| Cell Survival | 1 | 2020 | 612 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2017 | 129 | 0.150 |
Why?
|
| Pyrroles | 2 | 2008 | 71 | 0.150 |
Why?
|
| Virus Replication | 1 | 2019 | 150 | 0.150 |
Why?
|
| Genes, T-Cell Receptor delta | 1 | 2017 | 1 | 0.150 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2018 | 32 | 0.150 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 4 | 2006 | 33 | 0.150 |
Why?
|
| Oogenesis | 1 | 2017 | 18 | 0.140 |
Why?
|
| Microsomes, Liver | 1 | 2019 | 184 | 0.140 |
Why?
|
| Music | 1 | 2018 | 5 | 0.140 |
Why?
|
| Ticlopidine | 1 | 2018 | 56 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 1546 | 0.140 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 361 | 0.140 |
Why?
|
| Ubiquitination | 3 | 2025 | 47 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 505 | 0.140 |
Why?
|
| Electric Stimulation | 2 | 2014 | 107 | 0.140 |
Why?
|
| Mice, Transgenic | 4 | 2025 | 552 | 0.140 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2018 | 58 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 1165 | 0.140 |
Why?
|
| DNA Modification Methylases | 1 | 2017 | 28 | 0.140 |
Why?
|
| Amnion | 1 | 2017 | 13 | 0.140 |
Why?
|
| Interferon Type I | 1 | 2018 | 27 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 4 | 2020 | 278 | 0.140 |
Why?
|
| HIV-1 | 1 | 2018 | 59 | 0.140 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2017 | 10 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 316 | 0.140 |
Why?
|
| Herpesvirus 4, Human | 1 | 2017 | 43 | 0.140 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2017 | 32 | 0.140 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2017 | 5 | 0.140 |
Why?
|
| DNA Repair Enzymes | 1 | 2017 | 43 | 0.140 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 639 | 0.140 |
Why?
|
| Social Media | 1 | 2019 | 117 | 0.140 |
Why?
|
| Genomics | 3 | 2024 | 268 | 0.140 |
Why?
|
| Virus Activation | 1 | 2017 | 39 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2025 | 603 | 0.140 |
Why?
|
| Cathepsin F | 1 | 2017 | 1 | 0.140 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 14 | 0.140 |
Why?
|
| Sulfur Dioxide | 1 | 2017 | 4 | 0.140 |
Why?
|
| Chlorine | 1 | 2017 | 4 | 0.140 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 483 | 0.140 |
Why?
|
| Climate Change | 1 | 2018 | 53 | 0.140 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 101 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 284 | 0.140 |
Why?
|
| Location Directories and Signs | 1 | 2017 | 1 | 0.140 |
Why?
|
| Primary Health Care | 1 | 2021 | 376 | 0.140 |
Why?
|
| Lymphatic System | 2 | 2017 | 16 | 0.140 |
Why?
|
| Galactosyltransferases | 1 | 2017 | 8 | 0.140 |
Why?
|
| Ligands | 2 | 2016 | 206 | 0.140 |
Why?
|
| Ventricular Remodeling | 1 | 2017 | 64 | 0.140 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 436 | 0.140 |
Why?
|
| Endocytosis | 1 | 2017 | 52 | 0.140 |
Why?
|
| Swine | 3 | 2024 | 428 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2019 | 216 | 0.140 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2017 | 8 | 0.140 |
Why?
|
| Synteny | 1 | 2016 | 7 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2020 | 689 | 0.130 |
Why?
|
| Paclitaxel | 1 | 2017 | 89 | 0.130 |
Why?
|
| Stroke | 1 | 2022 | 512 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 490 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 326 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2016 | 11 | 0.130 |
Why?
|
| Bone Density | 4 | 2011 | 399 | 0.130 |
Why?
|
| Embryo, Mammalian | 4 | 2020 | 67 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 130 | 0.130 |
Why?
|
| Automobile Driving | 1 | 2017 | 27 | 0.130 |
Why?
|
| Immunohistochemistry | 5 | 2021 | 979 | 0.130 |
Why?
|
| Urothelium | 1 | 2016 | 19 | 0.130 |
Why?
|
| Biomimetic Materials | 1 | 2016 | 11 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 178 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 188 | 0.130 |
Why?
|
| Down-Regulation | 4 | 2025 | 346 | 0.130 |
Why?
|
| Sepsis | 1 | 2019 | 239 | 0.130 |
Why?
|
| Missouri | 1 | 2016 | 66 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2017 | 101 | 0.130 |
Why?
|
| Mosaic Viruses | 1 | 2016 | 1 | 0.130 |
Why?
|
| Saccharum | 1 | 2016 | 1 | 0.130 |
Why?
|
| Receptors, CXCR3 | 1 | 2016 | 4 | 0.130 |
Why?
|
| Chemokine CXCL11 | 1 | 2016 | 7 | 0.130 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 378 | 0.130 |
Why?
|
| Chemokines | 2 | 2019 | 79 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 52 | 0.130 |
Why?
|
| Accidents, Traffic | 1 | 2017 | 90 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 93 | 0.130 |
Why?
|
| Chemokine CXCL10 | 1 | 2016 | 20 | 0.130 |
Why?
|
| Reaction Time | 1 | 2017 | 209 | 0.130 |
Why?
|
| Newcastle disease virus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Diet, High-Fat | 1 | 2018 | 236 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 121 | 0.130 |
Why?
|
| Telephone | 1 | 2016 | 71 | 0.130 |
Why?
|
| Radiotherapy | 2 | 2007 | 127 | 0.130 |
Why?
|
| Myoblasts | 1 | 2016 | 19 | 0.130 |
Why?
|
| Suburethral Slings | 1 | 2016 | 13 | 0.130 |
Why?
|
| Random Allocation | 3 | 2016 | 285 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2017 | 83 | 0.130 |
Why?
|
| ROC Curve | 3 | 2025 | 253 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2016 | 40 | 0.120 |
Why?
|
| Podoviridae | 1 | 2015 | 1 | 0.120 |
Why?
|
| Coliphages | 1 | 2015 | 2 | 0.120 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2015 | 9 | 0.120 |
Why?
|
| Cohort Effect | 1 | 2015 | 1 | 0.120 |
Why?
|
| Ovariectomy | 2 | 2014 | 113 | 0.120 |
Why?
|
| Fibroins | 1 | 2015 | 1 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2019 | 465 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 100 | 0.120 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 80 | 0.120 |
Why?
|
| Escherichia coli O157 | 1 | 2015 | 10 | 0.120 |
Why?
|
| Genome, Viral | 1 | 2016 | 83 | 0.120 |
Why?
|
| Maleates | 1 | 2015 | 1 | 0.120 |
Why?
|
| Saccharopine Dehydrogenases | 1 | 2015 | 1 | 0.120 |
Why?
|
| Polyethylenes | 1 | 2015 | 14 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 181 | 0.120 |
Why?
|
| beta-Cyclodextrins | 1 | 2015 | 17 | 0.120 |
Why?
|
| Symbiosis | 1 | 2015 | 12 | 0.120 |
Why?
|
| Patient Admission | 1 | 2015 | 78 | 0.120 |
Why?
|
| Kallikreins | 1 | 2015 | 19 | 0.120 |
Why?
|
| Interferon-gamma | 2 | 2018 | 180 | 0.120 |
Why?
|
| Decidua | 3 | 2021 | 9 | 0.120 |
Why?
|
| Interleukin-11 | 1 | 2015 | 6 | 0.120 |
Why?
|
| Prostate-Specific Antigen | 1 | 2015 | 44 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 78 | 0.120 |
Why?
|
| Smoking | 1 | 2019 | 520 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 288 | 0.120 |
Why?
|
| Tensile Strength | 2 | 2025 | 31 | 0.120 |
Why?
|
| Ducks | 1 | 2014 | 1 | 0.120 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 1 | 2014 | 1 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 86 | 0.120 |
Why?
|
| Escherichia coli Proteins | 1 | 2015 | 55 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 51 | 0.120 |
Why?
|
| Plant Diseases | 2 | 2025 | 12 | 0.120 |
Why?
|
| Influenza in Birds | 1 | 2014 | 6 | 0.120 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 185 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2015 | 73 | 0.120 |
Why?
|
| Transcription Factor CHOP | 1 | 2014 | 7 | 0.120 |
Why?
|
| Calmodulin | 1 | 2014 | 10 | 0.120 |
Why?
|
| Trophoblasts | 1 | 2015 | 31 | 0.120 |
Why?
|
| Titanium | 2 | 2025 | 36 | 0.120 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 32 | 0.110 |
Why?
|
| Nerve Growth Factors | 1 | 2014 | 28 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 34 | 0.110 |
Why?
|
| Tacrolimus | 1 | 2015 | 59 | 0.110 |
Why?
|
| Dose-Response Relationship, Radiation | 3 | 2010 | 184 | 0.110 |
Why?
|
| Auditory Perception | 1 | 2014 | 30 | 0.110 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2015 | 39 | 0.110 |
Why?
|
| Viral Proteins | 1 | 2016 | 164 | 0.110 |
Why?
|
| Fermentation | 1 | 2014 | 14 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 412 | 0.110 |
Why?
|
| Railroads | 1 | 2014 | 1 | 0.110 |
Why?
|
| Cognition | 1 | 2017 | 331 | 0.110 |
Why?
|
| Sequence Alignment | 3 | 2021 | 125 | 0.110 |
Why?
|
| Fat Body | 1 | 2014 | 8 | 0.110 |
Why?
|
| Finite Element Analysis | 1 | 2014 | 12 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2016 | 292 | 0.110 |
Why?
|
| Injections, Subcutaneous | 1 | 2014 | 51 | 0.110 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 619 | 0.110 |
Why?
|
| Half-Life | 1 | 2014 | 88 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2015 | 558 | 0.110 |
Why?
|
| Adsorption | 2 | 2024 | 19 | 0.110 |
Why?
|
| Protein Conformation | 3 | 2021 | 176 | 0.110 |
Why?
|
| Cerium | 1 | 2013 | 2 | 0.110 |
Why?
|
| Intestinal Diseases | 2 | 2019 | 26 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2025 | 1229 | 0.110 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2013 | 6 | 0.110 |
Why?
|
| Drug Resistance, Viral | 1 | 2013 | 8 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 111 | 0.110 |
Why?
|
| Seafood | 1 | 2013 | 9 | 0.110 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2014 | 29 | 0.110 |
Why?
|
| Hepatitis B | 1 | 2013 | 16 | 0.110 |
Why?
|
| Hepatitis B virus | 1 | 2013 | 24 | 0.110 |
Why?
|
| Food Contamination | 1 | 2013 | 37 | 0.110 |
Why?
|
| HIV Infections | 1 | 2018 | 389 | 0.110 |
Why?
|
| Pancreatitis | 1 | 2014 | 64 | 0.100 |
Why?
|
| Homeostasis | 1 | 2014 | 201 | 0.100 |
Why?
|
| Protein Transport | 1 | 2014 | 180 | 0.100 |
Why?
|
| RNA Interference | 2 | 2017 | 181 | 0.100 |
Why?
|
| Carcinoma | 1 | 2014 | 138 | 0.100 |
Why?
|
| Telemedicine | 1 | 2019 | 494 | 0.100 |
Why?
|
| Vibrio | 3 | 2017 | 3 | 0.100 |
Why?
|
| Nerve Fibers | 1 | 2013 | 12 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 294 | 0.100 |
Why?
|
| Mucous Membrane | 3 | 2017 | 31 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2013 | 108 | 0.100 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 116 | 0.100 |
Why?
|
| Protein Interaction Maps | 2 | 2025 | 27 | 0.100 |
Why?
|
| Immune System | 1 | 2013 | 42 | 0.100 |
Why?
|
| Amino Acids | 1 | 2015 | 377 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 636 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2015 | 215 | 0.100 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 155 | 0.100 |
Why?
|
| Sensitivity and Specificity | 2 | 2025 | 891 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2015 | 478 | 0.100 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 3 | 2009 | 47 | 0.100 |
Why?
|
| Bandages | 2 | 2023 | 28 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2024 | 1542 | 0.100 |
Why?
|
| Primates | 2 | 2023 | 22 | 0.100 |
Why?
|
| Organ Specificity | 2 | 2016 | 115 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2013 | 95 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 235 | 0.100 |
Why?
|
| Atmosphere | 2 | 2023 | 11 | 0.100 |
Why?
|
| Myosin Heavy Chains | 2 | 2025 | 25 | 0.100 |
Why?
|
| Bone Demineralization, Pathologic | 1 | 2011 | 5 | 0.100 |
Why?
|
| Structure-Activity Relationship | 2 | 2025 | 404 | 0.090 |
Why?
|
| Soil | 2 | 2023 | 26 | 0.090 |
Why?
|
| Lactation | 1 | 2011 | 60 | 0.090 |
Why?
|
| Cellular Microenvironment | 2 | 2024 | 30 | 0.090 |
Why?
|
| Trypsin | 1 | 2011 | 11 | 0.090 |
Why?
|
| Pentoxifylline | 1 | 2010 | 13 | 0.090 |
Why?
|
| Skull | 3 | 2024 | 80 | 0.090 |
Why?
|
| Porosity | 2 | 2024 | 31 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2013 | 258 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2018 | 278 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2010 | 69 | 0.090 |
Why?
|
| Ecosystem | 2 | 2023 | 96 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2010 | 71 | 0.090 |
Why?
|
| Base Sequence | 2 | 2014 | 640 | 0.080 |
Why?
|
| Transplantation, Homologous | 2 | 2023 | 150 | 0.080 |
Why?
|
| Pupa | 1 | 2009 | 2 | 0.080 |
Why?
|
| Rivers | 2 | 2020 | 9 | 0.080 |
Why?
|
| Larva | 1 | 2009 | 32 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 43 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 56 | 0.080 |
Why?
|
| Leukocytes | 1 | 2010 | 66 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 2009 | 68 | 0.080 |
Why?
|
| Cesium Radioisotopes | 1 | 2009 | 3 | 0.080 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 2009 | 7 | 0.080 |
Why?
|
| Bacterial Translocation | 1 | 2009 | 15 | 0.080 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2009 | 9 | 0.080 |
Why?
|
| Cystectomy | 2 | 2021 | 51 | 0.080 |
Why?
|
| Core Binding Factor beta Subunit | 2 | 2025 | 4 | 0.080 |
Why?
|
| Cerebellum | 1 | 2010 | 125 | 0.080 |
Why?
|
| Interleukin-12 | 1 | 2009 | 27 | 0.080 |
Why?
|
| In Vitro Oocyte Maturation Techniques | 2 | 2020 | 3 | 0.080 |
Why?
|
| Blood Cells | 1 | 2009 | 45 | 0.080 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2020 | 64 | 0.080 |
Why?
|
| Age Factors | 3 | 2017 | 1132 | 0.080 |
Why?
|
| Embryonic Development | 2 | 2020 | 18 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2009 | 85 | 0.080 |
Why?
|
| Femur | 2 | 2024 | 135 | 0.080 |
Why?
|
| rho-Associated Kinases | 1 | 2008 | 18 | 0.080 |
Why?
|
| Microfluidics | 1 | 2008 | 7 | 0.080 |
Why?
|
| Shear Strength | 1 | 2008 | 10 | 0.080 |
Why?
|
| Citrulline | 1 | 2009 | 104 | 0.080 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 7 | 0.080 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 20 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2020 | 229 | 0.070 |
Why?
|
| 14-3-3 Proteins | 1 | 2008 | 18 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 36 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2021 | 204 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 92 | 0.070 |
Why?
|
| Genetic Markers | 2 | 2025 | 109 | 0.070 |
Why?
|
| Zea mays | 2 | 2019 | 11 | 0.070 |
Why?
|
| Polyglycolic Acid | 2 | 2017 | 7 | 0.070 |
Why?
|
| Caco-2 Cells | 2 | 2017 | 31 | 0.070 |
Why?
|
| Peroxynitrous Acid | 3 | 2013 | 33 | 0.070 |
Why?
|
| Simvastatin | 1 | 2007 | 29 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2008 | 362 | 0.070 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2008 | 109 | 0.070 |
Why?
|
| Hypolipidemic Agents | 1 | 2007 | 29 | 0.070 |
Why?
|
| Hospitalization | 2 | 2023 | 736 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2006 | 10 | 0.070 |
Why?
|
| Transcription Initiation Site | 1 | 2006 | 14 | 0.070 |
Why?
|
| Base Pairing | 1 | 2006 | 27 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2006 | 53 | 0.070 |
Why?
|
| Osteoporosis | 2 | 2025 | 162 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2007 | 272 | 0.060 |
Why?
|
| Mice, Inbred CBA | 2 | 2017 | 37 | 0.060 |
Why?
|
| Mice, Inbred DBA | 2 | 2017 | 47 | 0.060 |
Why?
|
| Sex Factors | 2 | 2020 | 727 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2022 | 105 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2017 | 144 | 0.060 |
Why?
|
| Arthropod Proteins | 1 | 2025 | 2 | 0.060 |
Why?
|
| Dioxygenases | 1 | 2025 | 5 | 0.060 |
Why?
|
| Acrylic Resins | 1 | 2025 | 3 | 0.060 |
Why?
|
| Recombinases | 1 | 2025 | 10 | 0.060 |
Why?
|
| Materials Testing | 2 | 2016 | 58 | 0.060 |
Why?
|
| Siloxanes | 1 | 2025 | 2 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2017 | 135 | 0.060 |
Why?
|
| Malondialdehyde | 2 | 2019 | 54 | 0.060 |
Why?
|
| NAD | 1 | 2025 | 45 | 0.060 |
Why?
|
| Binding Sites | 1 | 2006 | 377 | 0.060 |
Why?
|
| Goats | 1 | 2025 | 13 | 0.060 |
Why?
|
| Recombination, Genetic | 2 | 2016 | 109 | 0.060 |
Why?
|
| HCT116 Cells | 1 | 2025 | 30 | 0.060 |
Why?
|
| Nomograms | 1 | 2025 | 7 | 0.060 |
Why?
|
| Decision Trees | 1 | 2025 | 22 | 0.060 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2025 | 2 | 0.060 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2025 | 9 | 0.060 |
Why?
|
| Glucose Oxidase | 1 | 2025 | 6 | 0.060 |
Why?
|
| HLA-DRB1 Chains | 1 | 2025 | 5 | 0.060 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2025 | 3 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 1 | 2025 | 19 | 0.060 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2025 | 34 | 0.060 |
Why?
|
| Nephrectomy | 2 | 2016 | 82 | 0.060 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 108 | 0.060 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2025 | 34 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 58 | 0.060 |
Why?
|
| Spermatids | 1 | 2024 | 4 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2025 | 28 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2025 | 31 | 0.060 |
Why?
|
| Genome, Plant | 1 | 2024 | 10 | 0.060 |
Why?
|
| Ultrasonic Therapy | 1 | 2025 | 33 | 0.060 |
Why?
|
| Histone Demethylases | 1 | 2025 | 19 | 0.060 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2025 | 50 | 0.060 |
Why?
|
| Vitis | 1 | 2024 | 7 | 0.060 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2025 | 34 | 0.060 |
Why?
|
| Organ Size | 2 | 2022 | 228 | 0.060 |
Why?
|
| Chick Embryo | 1 | 2024 | 81 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2025 | 84 | 0.060 |
Why?
|
| Food Packaging | 1 | 2024 | 7 | 0.060 |
Why?
|
| SEER Program | 1 | 2025 | 103 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2024 | 3 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2024 | 5 | 0.060 |
Why?
|
| Species Specificity | 2 | 2016 | 192 | 0.060 |
Why?
|
| Aquaculture | 1 | 2024 | 4 | 0.060 |
Why?
|
| Debridement | 1 | 2024 | 48 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2024 | 55 | 0.060 |
Why?
|
| Methylation | 1 | 2025 | 126 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 61 | 0.060 |
Why?
|
| Hearing | 1 | 2025 | 63 | 0.060 |
Why?
|
| Feces | 1 | 2025 | 153 | 0.060 |
Why?
|
| Tibia | 1 | 2025 | 113 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2025 | 51 | 0.060 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 22 | 0.060 |
Why?
|
| Phytoplankton | 1 | 2024 | 19 | 0.060 |
Why?
|
| Penile Erection | 1 | 2024 | 24 | 0.060 |
Why?
|
| Catalysis | 1 | 2024 | 88 | 0.060 |
Why?
|
| Diatoms | 1 | 2024 | 24 | 0.060 |
Why?
|
| Manganese Compounds | 1 | 2024 | 3 | 0.060 |
Why?
|
| Immunomodulation | 1 | 2024 | 38 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2025 | 185 | 0.060 |
Why?
|
| Oxides | 1 | 2024 | 21 | 0.060 |
Why?
|
| Photosensitizing Agents | 1 | 2024 | 20 | 0.050 |
Why?
|
| Chondrocytes | 1 | 2024 | 41 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 1678 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2024 | 61 | 0.050 |
Why?
|
| Ureteral Obstruction | 1 | 2024 | 62 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2025 | 395 | 0.050 |
Why?
|
| Disease-Free Survival | 1 | 2025 | 460 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 772 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2024 | 66 | 0.050 |
Why?
|
| Rutin | 1 | 2023 | 4 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 40 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2024 | 94 | 0.050 |
Why?
|
| Photons | 1 | 2023 | 20 | 0.050 |
Why?
|
| Hydrogenation | 1 | 2023 | 3 | 0.050 |
Why?
|
| Administration, Cutaneous | 1 | 2023 | 55 | 0.050 |
Why?
|
| Needles | 1 | 2023 | 25 | 0.050 |
Why?
|
| Erythrocyte Count | 1 | 2023 | 4 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 67 | 0.050 |
Why?
|
| Wetlands | 1 | 2023 | 5 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 81 | 0.050 |
Why?
|
| Valproic Acid | 1 | 2023 | 35 | 0.050 |
Why?
|
| Histones | 1 | 2025 | 314 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 121 | 0.050 |
Why?
|
| Acupuncture Points | 1 | 2023 | 2 | 0.050 |
Why?
|
| Metabolomics | 1 | 2024 | 150 | 0.050 |
Why?
|
| Omentum | 1 | 2023 | 16 | 0.050 |
Why?
|
| Platelet Count | 1 | 2023 | 75 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 15 | 0.050 |
Why?
|
| United States | 2 | 2025 | 5192 | 0.050 |
Why?
|
| Neutrophils | 1 | 2024 | 147 | 0.050 |
Why?
|
| Computers | 1 | 2023 | 48 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2023 | 72 | 0.050 |
Why?
|
| Receptors, GABA-B | 1 | 2023 | 12 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2023 | 36 | 0.050 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2022 | 2 | 0.050 |
Why?
|
| Ketoglutaric Acids | 1 | 2022 | 3 | 0.050 |
Why?
|
| Electroencephalography | 1 | 2025 | 312 | 0.050 |
Why?
|
| Nucleus Accumbens | 1 | 2023 | 27 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 213 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2024 | 215 | 0.050 |
Why?
|
| Estrenes | 1 | 2002 | 11 | 0.050 |
Why?
|
| Constipation | 1 | 2023 | 37 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2025 | 235 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 118 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2024 | 4076 | 0.050 |
Why?
|
| Morocco | 1 | 2022 | 2 | 0.050 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 33 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2023 | 155 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 39 | 0.050 |
Why?
|
| Glutarates | 1 | 2022 | 8 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2023 | 62 | 0.050 |
Why?
|
| Fruit | 1 | 2023 | 128 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2002 | 61 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 172 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 236 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 139 | 0.050 |
Why?
|
| Cell Respiration | 1 | 2022 | 41 | 0.050 |
Why?
|
| Myeloid Cells | 1 | 2022 | 39 | 0.050 |
Why?
|
| Microbial Interactions | 1 | 2021 | 7 | 0.050 |
Why?
|
| Calcification, Physiologic | 1 | 2022 | 42 | 0.050 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2021 | 10 | 0.050 |
Why?
|
| Sirtuin 3 | 1 | 2022 | 18 | 0.050 |
Why?
|
| Bleomycin | 1 | 2022 | 38 | 0.050 |
Why?
|
| Spatial Analysis | 1 | 2021 | 20 | 0.050 |
Why?
|
| Xanthomonas campestris | 1 | 2021 | 1 | 0.050 |
Why?
|
| Pregnancy Trimester, First | 1 | 2021 | 23 | 0.050 |
Why?
|
| Immunity | 1 | 2021 | 39 | 0.050 |
Why?
|
| Hydrogen Bonding | 1 | 2021 | 35 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2021 | 92 | 0.050 |
Why?
|
| Hemostatics | 1 | 2021 | 17 | 0.050 |
Why?
|
| Oxygen | 1 | 2024 | 336 | 0.050 |
Why?
|
| Body Temperature | 1 | 2021 | 78 | 0.050 |
Why?
|
| Inosine | 1 | 2020 | 2 | 0.040 |
Why?
|
| Adenosine Deaminase | 1 | 2020 | 5 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 156 | 0.040 |
Why?
|
| Sperm Maturation | 1 | 2020 | 1 | 0.040 |
Why?
|
| Obstetrical Forceps | 1 | 2020 | 6 | 0.040 |
Why?
|
| Placenta Previa | 1 | 2020 | 7 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2020 | 23 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 747 | 0.040 |
Why?
|
| Waist-Hip Ratio | 1 | 2020 | 9 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2020 | 98 | 0.040 |
Why?
|
| Hydrolyzable Tannins | 1 | 2020 | 4 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2022 | 211 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2020 | 21 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 2 | 2010 | 62 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2020 | 82 | 0.040 |
Why?
|
| Glucosides | 1 | 2020 | 23 | 0.040 |
Why?
|
| Body Weight | 2 | 2018 | 523 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 57 | 0.040 |
Why?
|
| Placenta Accreta | 1 | 2020 | 26 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 29 | 0.040 |
Why?
|
| Birth Weight | 1 | 2020 | 125 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 123 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2022 | 713 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 108 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 39 | 0.040 |
Why?
|
| Incidence | 2 | 2017 | 1062 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2021 | 348 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2022 | 275 | 0.040 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2019 | 11 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2020 | 62 | 0.040 |
Why?
|
| Azepines | 1 | 2019 | 21 | 0.040 |
Why?
|
| Disulfides | 1 | 2019 | 17 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 60 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 94 | 0.040 |
Why?
|
| Breeding | 1 | 2019 | 7 | 0.040 |
Why?
|
| Sperm Motility | 1 | 2019 | 12 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2020 | 79 | 0.040 |
Why?
|
| Carboxylic Acids | 1 | 2019 | 18 | 0.040 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2019 | 17 | 0.040 |
Why?
|
| Environmental Pollution | 1 | 2019 | 14 | 0.040 |
Why?
|
| Critical Illness | 1 | 2022 | 317 | 0.040 |
Why?
|
| Cities | 1 | 2019 | 30 | 0.040 |
Why?
|
| Semen | 1 | 2019 | 22 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 120 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2019 | 15 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 25 | 0.040 |
Why?
|
| Dynamins | 1 | 2019 | 9 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2021 | 199 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 406 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2019 | 49 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 195 | 0.040 |
Why?
|
| Honduras | 1 | 2019 | 2 | 0.040 |
Why?
|
| YY1 Transcription Factor | 1 | 2019 | 7 | 0.040 |
Why?
|
| Algorithms | 1 | 2023 | 672 | 0.040 |
Why?
|
| Acute Disease | 1 | 2020 | 373 | 0.040 |
Why?
|
| Spouses | 1 | 2019 | 11 | 0.040 |
Why?
|
| Alkalies | 1 | 2019 | 5 | 0.040 |
Why?
|
| Cellulose | 1 | 2019 | 4 | 0.040 |
Why?
|
| Plant Stems | 1 | 2019 | 13 | 0.040 |
Why?
|
| Biofuels | 1 | 2019 | 6 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 240 | 0.040 |
Why?
|
| Chemical Fractionation | 1 | 2019 | 17 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2019 | 69 | 0.040 |
Why?
|
| Gestational Age | 1 | 2020 | 417 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 182 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 58 | 0.040 |
Why?
|
| Weaning | 1 | 2018 | 30 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2019 | 57 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2019 | 70 | 0.040 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2018 | 31 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2018 | 5 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2018 | 31 | 0.040 |
Why?
|
| Schwann Cells | 1 | 2018 | 14 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 60 | 0.040 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 16 | 0.040 |
Why?
|
| Granzymes | 1 | 2018 | 11 | 0.040 |
Why?
|
| Plant Components, Aerial | 1 | 2018 | 5 | 0.040 |
Why?
|
| X-Ray Diffraction | 1 | 2018 | 11 | 0.040 |
Why?
|
| Computational Biology | 1 | 2020 | 212 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2018 | 26 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 625 | 0.040 |
Why?
|
| Intention | 1 | 2019 | 48 | 0.040 |
Why?
|
| Choristoma | 1 | 2018 | 23 | 0.040 |
Why?
|
| Gap Junctions | 1 | 2018 | 27 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 163 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 85 | 0.040 |
Why?
|
| Embryo Culture Techniques | 1 | 2017 | 1 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2019 | 128 | 0.040 |
Why?
|
| Silicon | 1 | 2018 | 9 | 0.040 |
Why?
|
| Recurrence | 1 | 2020 | 672 | 0.040 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 5 | 0.040 |
Why?
|
| Fertilization in Vitro | 1 | 2017 | 31 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2020 | 268 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 136 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 18 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2018 | 71 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 58 | 0.040 |
Why?
|
| Isotopes | 1 | 2018 | 25 | 0.040 |
Why?
|
| Carboplatin | 1 | 2017 | 57 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2017 | 34 | 0.040 |
Why?
|
| Communication | 1 | 2019 | 257 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2010 | 262 | 0.040 |
Why?
|
| Photoelectron Spectroscopy | 1 | 2017 | 7 | 0.040 |
Why?
|
| Adipocytes | 1 | 2018 | 132 | 0.040 |
Why?
|
| Haplotypes | 1 | 2017 | 92 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2017 | 56 | 0.030 |
Why?
|
| Ions | 1 | 2017 | 32 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 124 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2017 | 46 | 0.030 |
Why?
|
| Speech Discrimination Tests | 1 | 2017 | 6 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2017 | 62 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 71 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1026 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 87 | 0.030 |
Why?
|
| Sodium | 1 | 2017 | 95 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 46 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2018 | 136 | 0.030 |
Why?
|
| Environment Design | 1 | 2017 | 26 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 59 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 194 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 610 | 0.030 |
Why?
|
| Polyproteins | 1 | 2016 | 3 | 0.030 |
Why?
|
| Mechanical Phenomena | 1 | 2016 | 9 | 0.030 |
Why?
|
| Cell Shape | 1 | 2016 | 21 | 0.030 |
Why?
|
| Cerulenin | 1 | 2016 | 1 | 0.030 |
Why?
|
| Fatty Acid Synthesis Inhibitors | 1 | 2016 | 1 | 0.030 |
Why?
|
| Cercopithecus aethiops | 1 | 2016 | 1 | 0.030 |
Why?
|
| Actin Cytoskeleton | 1 | 2016 | 22 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2016 | 28 | 0.030 |
Why?
|
| Vero Cells | 1 | 2016 | 44 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2016 | 39 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 243 | 0.030 |
Why?
|
| Plant Leaves | 1 | 2016 | 44 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 111 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 64 | 0.030 |
Why?
|
| Geography | 1 | 2016 | 65 | 0.030 |
Why?
|
| Models, Biological | 2 | 2013 | 735 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 126 | 0.030 |
Why?
|
| Shiga Toxin 2 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Lysogeny | 1 | 2015 | 2 | 0.030 |
Why?
|
| Prophages | 1 | 2015 | 2 | 0.030 |
Why?
|
| Shiga Toxin | 1 | 2015 | 4 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2016 | 97 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 46 | 0.030 |
Why?
|
| Ferritins | 1 | 2015 | 36 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 93 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2015 | 39 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 101 | 0.030 |
Why?
|
| Chickens | 1 | 2016 | 107 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2016 | 242 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 585 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 52 | 0.030 |
Why?
|
| Perforin | 1 | 2015 | 12 | 0.030 |
Why?
|
| Particle Size | 1 | 2015 | 82 | 0.030 |
Why?
|
| Neurons | 1 | 2018 | 418 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 171 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 174 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2015 | 44 | 0.030 |
Why?
|
| Audiometry, Speech | 1 | 2014 | 1 | 0.030 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2015 | 78 | 0.030 |
Why?
|
| Goiter, Nodular | 1 | 2014 | 4 | 0.030 |
Why?
|
| Auditory Pathways | 1 | 2014 | 6 | 0.030 |
Why?
|
| Loudness Perception | 1 | 2014 | 10 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 62 | 0.030 |
Why?
|
| Sound Spectrography | 1 | 2014 | 14 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2015 | 117 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2019 | 592 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2014 | 190 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 234 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 144 | 0.030 |
Why?
|
| Iron | 1 | 2015 | 127 | 0.030 |
Why?
|
| Acoustics | 1 | 2014 | 34 | 0.030 |
Why?
|
| Receptor, erbB-3 | 1 | 2014 | 2 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 78 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2014 | 67 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2014 | 14 | 0.030 |
Why?
|
| Wolbachia | 1 | 2014 | 2 | 0.030 |
Why?
|
| Diet | 1 | 2018 | 587 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 2014 | 51 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 2014 | 16 | 0.030 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2014 | 8 | 0.030 |
Why?
|
| Gene Library | 1 | 2014 | 44 | 0.030 |
Why?
|
| Carbohydrates | 1 | 2014 | 41 | 0.030 |
Why?
|
| Kupffer Cells | 1 | 2013 | 12 | 0.030 |
Why?
|
| Shellfish | 1 | 2013 | 1 | 0.030 |
Why?
|
| Xenobiotics | 1 | 2014 | 31 | 0.030 |
Why?
|
| Crustacea | 1 | 2013 | 2 | 0.030 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2013 | 3 | 0.030 |
Why?
|
| Fresh Water | 1 | 2013 | 9 | 0.030 |
Why?
|
| Water Pollution | 1 | 2013 | 9 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 53 | 0.030 |
Why?
|
| Genome | 1 | 2014 | 62 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2014 | 199 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2013 | 37 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 13 | 0.030 |
Why?
|
| Cell Division | 2 | 2005 | 291 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2014 | 256 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2013 | 73 | 0.030 |
Why?
|
| Nerve Endings | 1 | 2013 | 1 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2013 | 31 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 18 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2020 | 2867 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 34 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 187 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 37 | 0.020 |
Why?
|
| Glutathione | 1 | 2013 | 305 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 3733 | 0.020 |
Why?
|
| GTP Cyclohydrolase | 1 | 2010 | 4 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2010 | 23 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 150 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 2279 | 0.020 |
Why?
|
| Vascular System Injuries | 1 | 2010 | 38 | 0.020 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 30 | 0.020 |
Why?
|
| Deoxyguanosine | 1 | 2010 | 27 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 190 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 154 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 74 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 116 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 673 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 554 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2008 | 71 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2008 | 64 | 0.020 |
Why?
|
| Vitamin D | 1 | 2009 | 90 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 221 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2007 | 20 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2007 | 11 | 0.020 |
Why?
|
| Thrombin | 1 | 2007 | 37 | 0.020 |
Why?
|
| Protein C | 1 | 2007 | 20 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 461 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 2007 | 16 | 0.020 |
Why?
|
| Pelvic Neoplasms | 1 | 2007 | 13 | 0.020 |
Why?
|
| Injections | 1 | 2005 | 61 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 106 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2005 | 45 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2005 | 162 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 374 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 2004 | 85 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 86 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2003 | 9 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2003 | 23 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2003 | 47 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 169 | 0.010 |
Why?
|
| Compressive Strength | 1 | 2002 | 12 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 2002 | 14 | 0.010 |
Why?
|
| Seminal Vesicles | 1 | 2002 | 13 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2003 | 117 | 0.010 |
Why?
|
| Orchiectomy | 1 | 2002 | 38 | 0.010 |
Why?
|
| Osteocalcin | 1 | 2002 | 45 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 168 | 0.010 |
Why?
|
| Uterus | 1 | 2002 | 88 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2002 | 131 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 460 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2002 | 114 | 0.010 |
Why?
|
| Estradiol | 1 | 2002 | 214 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 405 | 0.010 |
Why?
|